This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (92)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Donald W. Weaver, MD; Anna M. Ledgerwood, MD; Charles E. Lucas, MD; Roger Higgins, PhD; David L. Bouwman, MD; Stemple D. Johnson, MD

Arch Surg. 1978;113(4):387-392.

Abstract
• The effect of albumin when added to the resuscitation regimen of patients in hypovolemic shock was studied in a randomized prospective manner in 52 injured patients who received an average of 15.3 transfusions, 9.6 liters of balanced electrolyte solution, and 980 ml of fresh frozen plasma. Before and during operation, 27 patients received an average of 25 gm of albumin and 150 gm/day for three to five days.

Patients who received albumin had greater dependence on respiratory support, averaging eight days while receiving ventilatory support with volume ventilator compared with three days in patients not receiving albumin. Furthermore, patients receiving albumin had forced inspiratory oxygen/Pao₂ ratios that were statistically and significantly higher than those of patients not receiving albumin during all phases of their hospital course.

These effects were associated with increased plasma volumes caused by the oncotic effects of albumin and by its interference with saline diuresis. On the basis of this preliminary report, albumin seems to have a detrimental effect on respiratory function.

(Arch Surg 113:387-392, 1978)

Author Affiliations
From the Department of Surgery, Wayne State University, and the Emergency Surgical Service, Detroit General Hospital.

Footnotes
Accepted for publication Dec 12, 1977.

Read before the 85th annual meeting of the Western Surgical Association, Las Vegas, Nov 14, 1977.

Reprint requests to Department of Surgery, Wayne State University, 540 E Canfield Ave, Detroit, MI 48201 (Dr Lucas).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of Intraoperative Hetastarch Priming During Coronary Bypass
Canver and Nichols
Chest 2000;118:1616-1620.
ABSTRACT | FULL TEXT  

The Good, the Bad, and the Ugly: Should We Completely Banish Human Albumin from Our Intensive Care Units?
Boldt
Anesth. Analg. 2000;91:887-895.
ABSTRACT | FULL TEXT  

Human albumin administration in critically ill patients: systematic review of randomised controlled trials • Why albumin may not work
Reviewers and Reviewers
BMJ 1998;317:235-240.
ABSTRACT | FULL TEXT  

Albumin and Nonprotein Colloid Solution Use in US Academic Health Centers
Yim et al.
Arch Intern Med 1995;155:2450-2455.
ABSTRACT  

Use of Albumin as a Volume Expander
Doweiko and Nompleggi
JPEN J Parenter Enteral Nutr 1991;15:484-487.
ABSTRACT  

Massive Transfusion in the Intensive Care Unit
Higgins and Klein
J Intensive Care Med 1989;4:221-233.
ABSTRACT  

Aspects of the Management of Shock
SHINE et al.
ANN INTERN MED 1980;93:723-734.
ABSTRACT  

Altered Coagulation After Albumin Supplements for Treatment of Oligemic Shock
Johnson et al.
Arch Surg 1979;114:379-383.
ABSTRACT